Skip to Main Content

Paper Details

Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy.
JTO Clin Res Rep
5
2021
Author NameAffiliation
Ming-Sound TsaoPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Geoffrey LiuPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Frances A ShepherdPrincess Margaret Cancer Centre, University Health Network, University of Toronto
  • 1 - 3

Datasets

Release 1.2